Pharmacological activities of berberine and strategies to improve its oral bioavailability

Jian-xiong ZHOU; Song-gu WU; Jun-bo GONG; Zhen-ping WEI.
Acta Pharmaceutica Sinica ; (12): 1263-1272, 2022.
Artículo en Zh | WPRIM | ID: wpr-924738

Documentos relacionados

  1. Approaches to minimize the effects of P-glycoprotein in drug transport: A review.
  2. Non-ionic Surfactants as a P-Glycoprotein(P-gp) Efflux Inhibitor for Optimal Drug Delivery-A Concise Outlook.
  3. Effects of hypoxia on the expression and function of P-gp in Caco-2 cells.
  4. Combining Machine Learning and Molecular Dynamics to Predict P-Glycoprotein Substrates.
  5. Piperine phytosomes for bioavailability enhancement of domperidone.
  6. Influence of piperine and omeprazole on the regional absorption of Daclatasvir from rabbit intestine.
  7. Effects of Two Natural Bisbenzylisoquinolines, Curine and Guattegaumerine, Extracted from <i>Isolona hexaloba</i> on Rhodamine Efflux by Abcb1b from Rat Glycocholic-Acid-Resistant Hepatocarcinoma Cells.
  8. Approaching strategy to increase the oral bioavailability of berberine, a quaternary ammonium isoquinoline alkaloid: part 2. development of oral dosage formulations.
  9. BI-2865, a pan-KRAS inhibitor, reverses the P-glycoprotein induced multidrug resistance in vitro and in vivo.
  10. Cryo-EM structure of P-glycoprotein bound to triple elacridar inhibitor molecules.